----item----
version: 1
id: {F5B35F40-15A3-4E02-9F73-466A4990C404}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/MainStory/2008/09/07/SC00000020
parent: {E331F80B-3658-4BA1-AB2B-54540453813C}
name: SC00000020
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: b95144b6-203d-467d-b864-d3fdd15b4bf5

----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 38

{B2967A9C-ABDA-4628-A672-9EDDCD142AEA}
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 26

Daiichi Sankyo joins IFPMA
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 10

SC00000020
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 1150

<p>Daiichi-Sankyo, Japan's third-largest drugs company, has joined the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), in a bid to expand its international presence.</p><p>It will join other major pharmaceutical companies, including Abbott, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer and Novartis, as members of the global federation.</p><p>Reinhard Bauer, CEO of Daiichi-Sankyo Europe, said joining the IFPMA would help the company reach its goal of becoming one of Europe's leading pharmaceutical companies by 2015 and generate 70% of turnover outside Japan, as well as providing the company with support and information about political activities in the world's healthcare markets.</p><p>Daiichi-Sankyo recently announced plans to acquire a majority holding in Ranbaxy Laboratories, in a share bid worth between $3.4 billion and $4.6 billion, the largest ever buyout transaction of a listed Indian company. On completion of the holding, Daiichi will gain significant strength in the US generics market, where Ranbaxy achieved $419 million of its total sales last year (<i>Scrip</i> Online, June 11th, 2008).</p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 10

SC00000020
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20080907T000000
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20080907T000000
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20080907T000000
----field----
field: {2C985172-2B37-4CFE-AEDE-2A42EC833941}
name: Content Type
key: content type
content-length: 38

{832554E5-EC9E-4747-8623-6770D36CAF32}
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 26

Daiichi Sankyo joins IFPMA
----field----
field: {5AD65E47-7554-4CE5-87B0-7FB65051C05A}
name: Authors
key: authors
content-length: 38

{B760B857-A14B-4919-89C7-9A8B352DA334}
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 4

News
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 3

644
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160119T221708Z
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

b95144b6-203d-467d-b864-d3fdd15b4bf5
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160119T221708Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 14

sitecore\admin
